Abstract
Both overt (OHT) and subclinical hypothyroid (SHT) disorders have been found to be associated with increased oxidative stress (OXS). Excess thyrotropin [thyroid stimulating hormone (TSH)] is known to directly produce OXS. Increased lipid peroxidation is known to facilitate protein carbonylation. However, the associations between lipid and protein oxidation and elevated TSH levels have not been studied. Thyroid profile, lipid peroxidation as malondialdehyde (MDA) levels and protein carbonylation as protein carbonyls (PCO) were estimated in OHT and SHT groups consisting of 36 patients each, in comparison to 39 euthyroid controls. We also determined the associations between TSH, MDA, and PCO levels in OHT and SHT groups. Increased oxidative damage was evidenced through significant elevations in the concentrations of MDA and PCO in OHT and SHT groups compared to controls (p < 0.01). Both TSH and MDA levels were positively associated with PCO in OHT group. Partial correlation analysis revealed that both excess TSH and increased MDA levels are mutually influencing elevated PCO. The results indicate that there is a simultaneous oxidative damage to lipids and proteins leading to increased MDA and PCO levels in both patient groups. Either of the excess TSH and increased MDA levels are combinably involved in the elevation of PCO in hypothyroidism.
Similar content being viewed by others
Abbreviations
- OHT:
-
Overt hypothyroidism
- SHT:
-
Subclinical hypothyroidism
- OXS:
-
Oxidative stress
- TSH:
-
Thyroid stimulating hormone (thyrotropin)
- MDA:
-
Malondialdehyde
- PCO:
-
Protein carbonyls
- ROS:
-
Reactive oxygen species
- DNA:
-
Deoxyribonucleic acid
- T3:
-
Tri-iodothyronine
- T4:
-
Tetra-iodothyronine
- RIA:
-
Radioimmunoassay
- IRMA:
-
Immunoradiometric assay
- DNPH:
-
Di-nitrophenyl hydrazine
- ANOVA:
-
Analysis of variance
- ROC:
-
Receiver operating characteristics curve
- AUC:
-
Area under curve
References
M. Valko, D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, J. Telser, Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44–84 (2007)
A.N. Torun, S. Kulaksizoglu, M. Kulaksizoglu, B.O. Pamuk, E. Isbilen, N.B. Tutuncu, Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Clin. Endocrinol. 70, 469–474 (2009)
G. Da Xiang, L.W. Xiang, H.L. He, L.S. Zhao, Post prandial lipaemia suppresses endothelium-dependent arterial dilation in patients with hypothyroidism. Endocrine 42, 391–398 (2012)
N. Nanda, Z. Bobby, A. Hamide, Association of thyroid stimulating hormone and coronary lipid risk factors with lipid peroxidation in hypothyroidism. Clin. Chem. Lab. Med. 46, 674–679 (2008)
L. Kebapcilar, B. Akinci, F. Bayraktar, A. Comlekci, A. Solak, T. Demir, S. Yener, T. Kume, S. Yesil, Plasma thiobarbituric acid-reactive substance levels in subclinical hypothyroidism. Med. Princ. Pract. 16, 432–436 (2007)
A. Dardano, L. Ghiadoni, Y. Plantinga, N. Caraccio, A. Bemi, E. Duranti, S. Taddei, E. Ferrannini, A. Salvetti, F. Monzani, Recombinant human TSH reduces endothelium dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 91, 4175–4178 (2006)
I. Kowalska, J. Borawski, A.S. Nikolajuk, T. Budlewski, E. Otziomek, M. Gorska, M. Straczkowski, Insulin sensitivity, plasma adiponectin and sICAM-1 in patients with subclinical hypothyroidism: response to levothyroxine therapy. Endocrine 40, 95–101 (2011)
N.A. Porter, Chemistry of lipid peroxidation. Methods Enzymol. 105, 273–282 (1984)
P.A. Grimsrud, H. Xie, T.J. Griffin, D.A. Bernlohr, Oxidative stress and covalent modification of protein with bioactive aldehydes. J. Biol. Chem. 283, 21837–21841 (2008)
I. Dalle-Donne, R. Rossi, D. Giustarini, A. Milzani, R. Colombo, Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 329, 23–38 (2003)
R. Ahmad, A.K. Tripathi, P. Tripathi, S. Singh, R. Singh, R.K. Singh, Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia. In Vivo 22, 525–528 (2008)
P. Sangeetha, U. Das, R. Koratkar, P. Suryaprabha, Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic. Biol. Med. 8, 15–19 (1990)
R.L. Levine, J. William, E.R. Stadtman, E. Shacter, Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233, 346–357 (1994)
N. Nanda, Z. Bobby, A. Hamide, Oxidative stress and protein glycation in primary hypothyroidism. Male/female difference. Clin. Exp. Med. 8, 101–108 (2008)
N. Nanda, Z. Bobby, A. Hamide, B.C. Koner, M.G. Sridhar, Association between oxidative stress and coronary lipid risk factors in hypothyroid women is independent of body mass index. Metabolism 56, 1350–1355 (2007)
B. Pereira, L.F. Rosa, D.A. Safi, E.J. Bechara, R. Curi, Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J. Endocrinol. 140, 73–77 (1994)
A. Santi, M.M. Duarte, R.N. Moresco, C. Menezes, M.D. Bagatini, M.R. Schetinger, V.L. Loro, Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clin. Chem. Lab. Med. 48, 1635–1639 (2010)
A.G. Dagre, J.P. Lekakis, T.G. Papaioannou, C.M. Papamichael, D.A. Koutras, S.F. Stamatelopoulos, M. Alevizaki, Arterial stiffness is increased in subjects with hypothyroidism. Int. J. Cardiol. 103, 1–6 (2005)
D. Donnini, F.S. Ambesi-Impiombato, F. Curcio, Thyroid stimulating hormone stimulates production of procoagulant and vasodilatative factors in human aortic endothelial cells. Thyroid 13, 517–521 (2003)
E.F. Kershaw, J.S. Flier, Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548–2556 (2004)
J.P. Coutlier, J.H. Kehrl, S.S. Bellur, L.D. Kohn, A.L. Notkins, B.S. Prabhakar, Binding and functional effects of thyroid stimulating hormone on human immune cells. J. Clin. Immunol. 10, 204–210 (1990)
G. Mazziotti, F. Sorvillo, M. Piscopo, M. Lioffi, P. Pilla, B. Biondi, S. Lorio, A. Giustina, G. Amato, C. Carella, Recombinant human TSH modulates in vivo C-telopeptides of type-I collagen and bone alkaline phosphatase, but not osteoprotegerin production in post menopausal women monitored for diffrentiated thyroid carcinoma. J. Bone Miner. Res. 20, 480–486 (2005)
G. Mazziotti, T. Porcelli, I. Patelli, P.P. Vescovi, A. Giustina, Serum TSH values and risk of vertebral fractures in euthyroid post menopausal women with low mineral density. Bone 46(3), 747–751 (2010)
M. Mark, P.J. Vanderpump, W. Michael, G. Tunbridge, How the Doctor Finds Out What is Wrong, in Thyroid Disease the Facts, 4th edn., ed. by M. Mark, P.J. Vanderpump, W. Michael, G. Tunbridge (Oxford University Press, New York, 2008), pp. 15–17
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haribabu, A., Reddy, V.S., Pallavi, C. et al. Evaluation of protein oxidation and its association with lipid peroxidation and thyrotropin levels in overt and subclinical hypothyroidism. Endocrine 44, 152–157 (2013). https://doi.org/10.1007/s12020-012-9849-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-012-9849-y